Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.470
+0.060 (4.26%)
Mar 31, 2025, 3:11 PM EDT - Market open
Ironwood Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 88.56 | 92.15 | 656.2 | 620.13 | 362.56 | Upgrade
|
| Cash & Short-Term Investments | 88.56 | 92.15 | 656.2 | 620.13 | 362.56 | Upgrade
|
| Cash Growth | -3.90% | -85.96% | 5.82% | 71.04% | 104.81% | Upgrade
|
| Accounts Receivable | 81.89 | 129.12 | 115.46 | 114.04 | 122.35 | Upgrade
|
| Receivables | 81.89 | 129.12 | 115.46 | 114.04 | 122.35 | Upgrade
|
| Prepaid Expenses | 11.97 | 12.01 | 7.72 | 8.69 | 9.19 | Upgrade
|
| Restricted Cash | - | - | 1.25 | 1.25 | 1.74 | Upgrade
|
| Other Current Assets | - | - | - | 1.12 | - | Upgrade
|
| Total Current Assets | 182.42 | 233.29 | 780.63 | 745.23 | 495.84 | Upgrade
|
| Property, Plant & Equipment | 15.52 | 18.17 | 20.31 | 22.93 | 25.51 | Upgrade
|
| Other Intangible Assets | 2.86 | 3.68 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 144.58 | 212.32 | 283.66 | 333.29 | - | Upgrade
|
| Long-Term Deferred Charges | - | 2.4 | - | - | - | Upgrade
|
| Other Long-Term Assets | 5.92 | 1.21 | 15.92 | 25.48 | 37.89 | Upgrade
|
| Total Assets | 351.3 | 471.07 | 1,101 | 1,127 | 559.24 | Upgrade
|
| Accounts Payable | 2.13 | 7.83 | 0.48 | 0.94 | 0.66 | Upgrade
|
| Accrued Expenses | 33.83 | 47.34 | 17.71 | 33.29 | 15.77 | Upgrade
|
| Current Portion of Long-Term Debt | - | 199.56 | - | 116.86 | - | Upgrade
|
| Current Portion of Leases | 3.19 | 3.13 | 3.07 | 3.13 | 3.13 | Upgrade
|
| Current Income Taxes Payable | - | 1.24 | 0.66 | - | - | Upgrade
|
| Current Unearned Revenue | - | 2.6 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 14.4 | 3.61 | 7.49 | 12.61 | Upgrade
|
| Total Current Liabilities | 39.15 | 276.1 | 25.53 | 161.7 | 32.17 | Upgrade
|
| Long-Term Debt | 583.99 | 498.31 | 396.25 | 337.33 | 430.26 | Upgrade
|
| Long-Term Leases | 12.3 | 14.54 | 16.6 | 18.48 | 20.32 | Upgrade
|
| Other Long-Term Liabilities | 17.11 | 28.42 | 9.77 | 3.5 | 13.85 | Upgrade
|
| Total Liabilities | 652.55 | 817.37 | 448.14 | 521.02 | 496.6 | Upgrade
|
| Common Stock | -301.25 | 0.16 | 0.15 | 0.16 | 0.16 | Upgrade
|
| Additional Paid-In Capital | - | 1,355 | 1,349 | 1,543 | 1,529 | Upgrade
|
| Retained Earnings | - | -1,699 | -696.38 | -937.61 | -1,466 | Upgrade
|
| Comprehensive Income & Other | - | -3.03 | - | - | - | Upgrade
|
| Shareholders' Equity | -301.25 | -346.3 | 652.38 | 605.91 | 62.64 | Upgrade
|
| Total Liabilities & Equity | 351.3 | 471.07 | 1,101 | 1,127 | 559.24 | Upgrade
|
| Total Debt | 599.48 | 715.54 | 415.92 | 475.8 | 453.7 | Upgrade
|
| Net Cash (Debt) | -510.92 | -623.38 | 240.29 | 144.33 | -91.14 | Upgrade
|
| Net Cash Growth | - | - | 66.49% | - | - | Upgrade
|
| Net Cash Per Share | -2.82 | -4.01 | 1.29 | 0.88 | -0.57 | Upgrade
|
| Filing Date Shares Outstanding | 159.45 | 156.53 | 154.16 | 159.22 | 160.96 | Upgrade
|
| Total Common Shares Outstanding | 159.45 | 156.35 | 154.03 | 162.04 | 160.62 | Upgrade
|
| Working Capital | 143.27 | -42.81 | 755.1 | 583.53 | 463.67 | Upgrade
|
| Book Value Per Share | -1.89 | -2.21 | 4.24 | 3.74 | 0.39 | Upgrade
|
| Tangible Book Value | -304.11 | -349.98 | 652.38 | 605.91 | 62.64 | Upgrade
|
| Tangible Book Value Per Share | -1.91 | -2.24 | 4.24 | 3.74 | 0.39 | Upgrade
|
| Machinery | - | 5.42 | 4.23 | 4.13 | 4.71 | Upgrade
|
| Leasehold Improvements | - | 7.41 | 7.41 | 7.41 | 7.41 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.